Lord, Abbett & Co’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-453,954
Closed -$3.11M 513
2023
Q3
$3.11M Buy
453,954
+55,602
+14% +$381K 0.01% 505
2023
Q2
$4.13M Buy
+398,352
New +$4.13M 0.01% 497